Rare diseases, though individually uncommon, collectively affect millions worldwide. This review explores the role of genomics in rare disease research, the impact of large consortium initiatives, advancements in extensive data analysis, the integration of artificial intelligence (AI) and machine learning (ML), and the therapeutic implications in precision medicine.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Dec 03, 2024 |
| Journal | Genomics & informatics |
| Authors | Hong Juhyeon, Lee Dajun, Hwang Ayoung, Kim Taekeun, Ryu Hong-Yeoul |
| DOI | 10.1186/s44342-024-00032-1 |
| Source | PubMed |